vs
Side-by-side financial comparison of CPI AEROSTRUCTURES INC (CVU) and TriSalus Life Sciences, Inc. (TLSI). Click either name above to swap in a different company.
CPI AEROSTRUCTURES INC is the larger business by last-quarter revenue ($19.4M vs $13.2M, roughly 1.5× TriSalus Life Sciences, Inc.). CPI AEROSTRUCTURES INC runs the higher net margin — 3.6% vs -73.9%, a 77.4% gap on every dollar of revenue. On growth, TriSalus Life Sciences, Inc. posted the faster year-over-year revenue change (59.8% vs -10.8%). CPI AEROSTRUCTURES INC produced more free cash flow last quarter ($-2.1M vs $-2.5M). Over the past eight quarters, TriSalus Life Sciences, Inc.'s revenue compounded faster (43.0% CAGR vs 0.9%).
CPI Aerostructures Inc., known as CPI Aero, is a contract aircraft component manufacturer based in Edgewood, New York.
TriSalus Life Sciences, Inc. is a clinical-stage biotechnology company focused on advancing immuno-oncology and interventional oncology solutions. It develops proprietary targeted drug delivery technologies designed to improve treatment efficacy for patients with liver, pancreatic and other hard-to-treat solid tumors, primarily operating in North American markets via partnerships with clinical care and research institutions.
CVU vs TLSI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $19.4M | $13.2M |
| Net Profit | $691.8K | $-9.8M |
| Gross Margin | 20.3% | 86.7% |
| Operating Margin | 6.4% | -24.8% |
| Net Margin | 3.6% | -73.9% |
| Revenue YoY | -10.8% | 59.8% |
| Net Profit YoY | -28.8% | 3.5% |
| EPS (diluted) | $0.04 | $-0.22 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $19.4M | $13.2M | ||
| Q3 25 | $19.3M | $11.6M | ||
| Q2 25 | $15.2M | $11.2M | ||
| Q1 25 | $15.4M | $9.2M | ||
| Q4 24 | $21.8M | $8.3M | ||
| Q3 24 | $19.4M | $7.3M | ||
| Q2 24 | $20.8M | $7.4M | ||
| Q1 24 | $19.1M | $6.5M |
| Q4 25 | $691.8K | $-9.8M | ||
| Q3 25 | $1.1M | $-10.8M | ||
| Q2 25 | $-1.3M | $-8.3M | ||
| Q1 25 | $-1.3M | $-10.4M | ||
| Q4 24 | $971.5K | $-10.1M | ||
| Q3 24 | $749.7K | $-2.4M | ||
| Q2 24 | $1.4M | $-4.3M | ||
| Q1 24 | $168.2K | $-13.2M |
| Q4 25 | 20.3% | 86.7% | ||
| Q3 25 | 22.3% | 83.5% | ||
| Q2 25 | 4.4% | 83.9% | ||
| Q1 25 | 10.7% | 83.7% | ||
| Q4 24 | 20.0% | 85.3% | ||
| Q3 24 | 21.7% | 86.3% | ||
| Q2 24 | 24.6% | 87.6% | ||
| Q1 24 | 18.6% | 85.0% |
| Q4 25 | 6.4% | -24.8% | ||
| Q3 25 | 9.1% | -77.9% | ||
| Q2 25 | -13.1% | -65.4% | ||
| Q1 25 | -7.7% | -79.9% | ||
| Q4 24 | 9.5% | -91.8% | ||
| Q3 24 | 7.6% | -118.9% | ||
| Q2 24 | 11.2% | -111.0% | ||
| Q1 24 | 4.4% | -180.8% |
| Q4 25 | 3.6% | -73.9% | ||
| Q3 25 | 5.8% | -93.5% | ||
| Q2 25 | -8.7% | -73.9% | ||
| Q1 25 | -8.6% | -113.2% | ||
| Q4 24 | 4.5% | -122.4% | ||
| Q3 24 | 3.9% | -32.6% | ||
| Q2 24 | 6.8% | -58.8% | ||
| Q1 24 | 0.9% | -204.5% |
| Q4 25 | $0.04 | $-0.22 | ||
| Q3 25 | $0.09 | $-0.96 | ||
| Q2 25 | $-0.10 | $-0.27 | ||
| Q1 25 | $-0.10 | $-0.39 | ||
| Q4 24 | $0.08 | $-0.38 | ||
| Q3 24 | $0.06 | $-0.12 | ||
| Q2 24 | $0.11 | $-0.21 | ||
| Q1 24 | $0.01 | $-0.60 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $20.4M |
| Total DebtLower is stronger | $0 | — |
| Stockholders' EquityBook value | $25.8M | $-33.9M |
| Total Assets | $75.2M | $35.3M |
| Debt / EquityLower = less leverage | 0.00× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $20.4M | ||
| Q3 25 | — | $22.7M | ||
| Q2 25 | — | $26.5M | ||
| Q1 25 | — | $13.0M | ||
| Q4 24 | — | $8.5M | ||
| Q3 24 | — | $11.3M | ||
| Q2 24 | — | $16.5M | ||
| Q1 24 | — | $4.0M |
| Q4 25 | $0 | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $26.5K | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $25.8M | $-33.9M | ||
| Q3 25 | $25.0M | $-26.7M | ||
| Q2 25 | $23.8M | $-19.4M | ||
| Q1 25 | $24.9M | $-34.4M | ||
| Q4 24 | $25.9M | $-25.9M | ||
| Q3 24 | $24.9M | $-20.4M | ||
| Q2 24 | $24.1M | $-25.3M | ||
| Q1 24 | $22.5M | $-36.0M |
| Q4 25 | $75.2M | $35.3M | ||
| Q3 25 | $74.1M | $36.5M | ||
| Q2 25 | $72.3M | $41.3M | ||
| Q1 25 | $65.4M | $28.6M | ||
| Q4 24 | $68.0M | $24.0M | ||
| Q3 24 | $68.9M | $27.5M | ||
| Q2 24 | $70.2M | $32.4M | ||
| Q1 24 | $70.8M | $17.9M |
| Q4 25 | 0.00× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.00× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-2.1M | $-2.5M |
| Free Cash FlowOCF − Capex | $-2.1M | $-2.5M |
| FCF MarginFCF / Revenue | -10.8% | -19.1% |
| Capex IntensityCapex / Revenue | 0.0% | 0.3% |
| Cash ConversionOCF / Net Profit | -3.03× | — |
| TTM Free Cash FlowTrailing 4 quarters | $-5.3M | $-19.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-2.1M | $-2.5M | ||
| Q3 25 | $212.1K | $-3.7M | ||
| Q2 25 | $-596.3K | $-7.3M | ||
| Q1 25 | $-2.7M | $-4.5M | ||
| Q4 24 | $4.4M | $-5.7M | ||
| Q3 24 | $715.1K | $-10.8M | ||
| Q2 24 | $-591.7K | $-13.4M | ||
| Q1 24 | $-960.5K | $-10.9M |
| Q4 25 | $-2.1M | $-2.5M | ||
| Q3 25 | $211.1K | $-3.9M | ||
| Q2 25 | $-599.8K | $-7.4M | ||
| Q1 25 | $-2.8M | $-5.3M | ||
| Q4 24 | $4.3M | $-5.8M | ||
| Q3 24 | $586.9K | $-11.0M | ||
| Q2 24 | $-746.9K | $-13.5M | ||
| Q1 24 | $-1.0M | $-10.9M |
| Q4 25 | -10.8% | -19.1% | ||
| Q3 25 | 1.1% | -33.9% | ||
| Q2 25 | -4.0% | -66.1% | ||
| Q1 25 | -18.1% | -57.3% | ||
| Q4 24 | 19.9% | -69.7% | ||
| Q3 24 | 3.0% | -149.9% | ||
| Q2 24 | -3.6% | -183.1% | ||
| Q1 24 | -5.3% | -169.3% |
| Q4 25 | 0.0% | 0.3% | ||
| Q3 25 | 0.0% | 1.9% | ||
| Q2 25 | 0.0% | 0.8% | ||
| Q1 25 | 0.4% | 8.2% | ||
| Q4 24 | 0.3% | 0.6% | ||
| Q3 24 | 0.7% | 2.3% | ||
| Q2 24 | 0.7% | 0.8% | ||
| Q1 24 | 0.2% | 1.0% |
| Q4 25 | -3.03× | — | ||
| Q3 25 | 0.19× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 4.53× | — | ||
| Q3 24 | 0.95× | — | ||
| Q2 24 | -0.42× | — | ||
| Q1 24 | -5.71× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CVU
| Government Subcontracts | $16.4M | 85% |
| Commercial Contracts | $2.3M | 12% |
| Prime Government Contracts | $725.8K | 4% |
TLSI
Segment breakdown not available.
